Showing results (171-180 of 759) with videos related to
Sort By:
Pageof 76
Nephron|June 15, 2021
Long-Term Outcomes of Kidney Transplants from Older/Marginal Donors: A Cohort StudyBoris Bikbov, Piero Ruggenenti, Annalisa Perna, et al.Blood|July 20, 2014
Dynamics of complement activation in aHUS and how to monitor eculizumab therapyMarina Noris, Miriam Galbusera, Sara Gastoldi, et al.Nature Reviews. Nephrology|October 27, 2009
Transplantation: time to rethink immunosuppression by mTOR inhibitors?Marcus D Säemann, Giuseppe RemuzziBMC Nephrology|July 13, 2016
Diets for patients with chronic kidney disease, should we reconsider?William E Mitch, Giuseppe RemuzziAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical TrialPiero Ruggenenti, Erica Daina, Alessia Gennarini, et al.Kidney International|March 1, 2013
The GFR and GFR decline cannot be accurately estimated in type 2 diabeticsFlavio Gaspari, Piero Ruggenenti, Esteban Porrini, et al.Journal of Hypertension|January 19, 2011
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trialPiero Ruggenenti, Anna Fassi, Aneliya Parvanova Ilieva, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over TrialMatias Trillini, Anna Caroli, Norberto Perico, et al.Nephron|January 24, 2021
Preimplantation Histological Score Associates with 6-Month GFR in Recipients of Perfused, Older Kidney Grafts: Results from a Pilot StudyCamillo Carrara, Paolo Cravedi, Annalisa Perna, et al.Journal of the American Society of Nephrology : JASN|April 27, 2007
Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trialGiuseppe Remuzzi, Paolo Cravedi, Marco Costantini, et al.Pageof 76